vs
Side-by-side financial comparison of ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $158.8M, roughly 1.9× ESSENTIAL PROPERTIES REALTY TRUST, INC.). ESSENTIAL PROPERTIES REALTY TRUST, INC. runs the higher net margin — 37.8% vs 12.8%, a 24.9% gap on every dollar of revenue. On growth, ESSENTIAL PROPERTIES REALTY TRUST, INC. posted the faster year-over-year revenue change (22.8% vs -6.4%). Over the past eight quarters, ESSENTIAL PROPERTIES REALTY TRUST, INC.'s revenue compounded faster (20.6% CAGR vs 4.2%).
Essential Properties Realty Trust is a publicly traded real estate investment trust (REIT) that acquires, owns and manages a diversified portfolio of single-tenant net-leased commercial properties across the United States. Its assets primarily cover essential service-oriented sectors including casual dining, automotive services, medical clinics, early childhood education centers and light industrial facilities, with tenants mostly holding robust long-term operating track records.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
EPRT vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $158.8M | $295.9M |
| Net Profit | $60.0M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 56.5% | 18.4% |
| Net Margin | 37.8% | 12.8% |
| Revenue YoY | 22.8% | -6.4% |
| Net Profit YoY | 6.5% | 68.3% |
| EPS (diluted) | $0.28 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $158.8M | — | ||
| Q4 25 | $149.9M | $295.9M | ||
| Q3 25 | $144.9M | — | ||
| Q2 25 | $137.1M | $317.0M | ||
| Q1 25 | $129.4M | $316.2M | ||
| Q4 24 | $119.7M | $297.0M | ||
| Q3 24 | $117.1M | $289.5M | ||
| Q2 24 | $109.3M | $306.1M |
| Q1 26 | $60.0M | — | ||
| Q4 25 | $68.1M | $38.0M | ||
| Q3 25 | $65.6M | — | ||
| Q2 25 | $63.2M | $-17.7M | ||
| Q1 25 | $56.1M | $22.6M | ||
| Q4 24 | $55.4M | $34.9M | ||
| Q3 24 | $49.1M | $33.6M | ||
| Q2 24 | $51.5M | $40.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | 56.5% | — | ||
| Q4 25 | 65.9% | 18.4% | ||
| Q3 25 | 64.7% | — | ||
| Q2 25 | 64.1% | -7.5% | ||
| Q1 25 | 61.6% | 12.2% | ||
| Q4 24 | 66.1% | 16.0% | ||
| Q3 24 | 59.7% | 13.8% | ||
| Q2 24 | 61.1% | 15.0% |
| Q1 26 | 37.8% | — | ||
| Q4 25 | 45.4% | 12.8% | ||
| Q3 25 | 45.3% | — | ||
| Q2 25 | 46.1% | -5.6% | ||
| Q1 25 | 43.4% | 7.1% | ||
| Q4 24 | 46.3% | 11.7% | ||
| Q3 24 | 42.0% | 11.6% | ||
| Q2 24 | 47.1% | 13.3% |
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.34 | $0.24 | ||
| Q3 25 | $0.33 | — | ||
| Q2 25 | $0.32 | $-0.11 | ||
| Q1 25 | $0.29 | $0.14 | ||
| Q4 24 | $0.31 | $0.22 | ||
| Q3 24 | $0.27 | $0.21 | ||
| Q2 24 | $0.29 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.2M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $4.4B | $2.0B |
| Total Assets | $7.2B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $15.2M | — | ||
| Q4 25 | $60.2M | $172.9M | ||
| Q3 25 | $23.8M | — | ||
| Q2 25 | $20.8M | $162.2M | ||
| Q1 25 | $47.0M | $140.7M | ||
| Q4 24 | $40.7M | $177.5M | ||
| Q3 24 | $32.7M | $187.5M | ||
| Q2 24 | $23.6M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $260.0M | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.3B | $346.0M | ||
| Q1 25 | $2.1B | $330.0M | ||
| Q4 24 | $2.1B | $300.0M | ||
| Q3 24 | $2.2B | $300.0M | ||
| Q2 24 | $1.9B | $319.0M |
| Q1 26 | $4.4B | — | ||
| Q4 25 | $4.2B | $2.0B | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.8B | $1.9B | ||
| Q1 25 | $3.8B | $2.0B | ||
| Q4 24 | $3.6B | $2.1B | ||
| Q3 24 | $3.2B | $2.1B | ||
| Q2 24 | $3.2B | $2.1B |
| Q1 26 | $7.2B | — | ||
| Q4 25 | $6.9B | $2.5B | ||
| Q3 25 | $6.6B | — | ||
| Q2 25 | $6.3B | $2.6B | ||
| Q1 25 | $6.1B | $2.6B | ||
| Q4 24 | $5.8B | $2.7B | ||
| Q3 24 | $5.5B | $2.7B | ||
| Q2 24 | $5.3B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.60× | 0.13× | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.61× | 0.18× | ||
| Q1 25 | 0.56× | 0.16× | ||
| Q4 24 | 0.60× | 0.14× | ||
| Q3 24 | 0.69× | 0.14× | ||
| Q2 24 | 0.59× | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPRT
| Rental revenue 1,2 | $149.4M | 94% |
| Other | $8.6M | 5% |
| Other revenue | $779.0K | 0% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
